drugset / Trial / NCT04689932
Triferic AVNU Infusion Via Freedom Pump During Hemodialysis
NaSequentialOpen-labelTreatment
Summary
The main purpose of this study is to evaluate the delivery of Triferic AVNU intravenously using the Freedom Pump-20 during hemodialysis into the pre-dialyzer and post-dialyzer blood lines.
Timeline
- Start
- 2021-04-19
- Primary completion
- 2021-06-19
- Completion
- 2021-06-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Triferic | Other / unclassified | 6.75 mg | Intravenous |